The following is a current list of our studies at the Asthma Research Center. All studies are open for enrollment, unless otherwise noted. The Asthma Research Center runs multiple studies and each study varies in duration and compensation is up to $1,530 for your time and effort. To see if you are eligible for any of our studies, please contact us at 617-732-8201 or via e-mail at ARC@partners.org. You can also click the link in the upper right corner of this page to fill out a form and see if you qualify to participate.
|
Results 1 - 4 of 5 total studies
Page 1 of 2
1
2
>> next |
|
|
|
|
|
•Are you 18 years or older?
•Have you been diagnosed with asthma?
ABOUT THE STUDY
You may be eligible for a research study, to find out if taking vitamin D in addition to an inhaled steroid called Alvesco® (ciclesonide) will help prevent asthma symptoms and asthma attacks from worsening.
•Participants will be screened for eligibility prior to study.
•Participants entering the study will receive Asthma medication (Alvesco) and Vitamin D or Placebo (sugar pill) for the duration of the study (35 weeks)
•You will be compensated up to $1010 for your time.
For more information, please contact:
[Asthma Research Center, 1-888-99-ASTHMA or ARC@Partners.org]
 more information on becoming a participant
|
|
|
If you are Black and take inhaled steroids for your asthma(i.e. Flovent, Advair, Symbicort, etc.) you may be eligible for a study testing a new approach to asthma treatment. This approach uses a medication (Tiotropium) that is FDA approved for certain lung conditions but has not been approved for the treatment of asthma. Participants will be randomly assigned (like the flip of a coin) either to stay on their current medications or to try a combination of their current inhaled steroid and Tiotropium. To qualify for the study, participants must be 18-75 years old and have been diagnosed with asthma for at least 1 year. The study involves 4 visits over a 12 month period and compensation is up to $175. For more information, please contact us at 617-732-8201 or 1-888-99-ASTHMA.
more information on becoming a participant
|
|
|
Are you between the ages of 18-75? Do you have asthma symptoms that limit your activities? Do you take asthma medications containing steroids like Flovent® and Advair®? You may be eligible to participate in a new study testing an experimental medication. The study is 52 weeks (1 year) long and involves 15 study visits. The medication, called reslizumab, has not yet been approved by the Food and Drug Administration for the treatment of asthma. Participants will receive the study medication at no cost and will be compensated up to $1,530. For more information, please contact us at 617-732-8201 or 1-888-99-ASTHMA.
more information on becoming a participant
|
|
|
Do you have asthma? The Asthma Research Center at Brigham and Women's Hospital is recruiting asthmatics aged 18-90 who have had asthma for at least 6 months. The study is 45 days long and involves 4 visits to the asthma research center with a Bronchoscopy at Visit 4, and the compensation is $320. No change to your current asthma medication will be required. Call us at 617-732-8201 or
1-888-99ASTHMA or email contact information to arc@partners.org to learn more.
more information on becoming a participant
|
|
 Return to top |
|
Results 1 - 4 of 5 total studies
Page 1 of 2
1
2
>> next |
|
|
